Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice

CompletedOBSERVATIONAL
Enrollment

309

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Vertigo
Trial Locations (24)

54001

Site reference ID 93475, Mykolaiv

61000

Site reference ID 93713, Kharkiv

69032

Site reference ID 95738, Zaporizhzhia

69060

Site reference ID 93455, Zaporizhzhia

76014

Site reference ID 93715, Ivano-Frankivsk

83045

Research facility ID ORG-000345, Donetsk

95006

Site reference ID 93474, Simferopol

99011

Site reference ID 93714, Sevastopol

119991

Site reference ID 89454, Moscow

123007

Site reference ID 89419, Moscow

125047

Research facility ID ORG-000837, Moscow

127006

Site reference ID 94374, Moscow

129110

Site reference ID 89416, Moscow

143007

Research facility ID ORG-000841, Odintsovo

198255

Site reference ID 89456, Saint Petersburg

308007

Site reference ID 89414, Belgorod

344010

Site reference ID 89453, Rostov-on-Don

400134

Site reference ID 89455, Volgograd

410012

Site reference ID 89418, Saratov

420012

Site reference ID 89433, Kazan'

450009

Site reference ID 89415, Ufa

630091

Site reference ID 89435, Novosibirsk

664047

Research facility ID ORG-000838, Irkutsk

04112

Site reference ID 93454, Kiev

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY